Glasdegib Maleate

CAS 1416576-73-4 1 FDA-DMF supplierSmall Molecule

Overview

Glasdegib Maleate is a small molecule inhibitor of the Hedgehog signaling pathway used in the treatment of certain types of cancer, including acute myeloid leukemia (AML). It functions by binding to and inhibiting the Smoothened (SMO) receptor, which plays a critical role in this pathway.

Therapeutic areas

Oncology

Related APIs

Paclitaxel
33 suppliers
Anastrozole
28 suppliers
Capecitabine
27 suppliers
Bicalutamide
26 suppliers
Zoledronic Acid
25 suppliers
Dasatinib
24 suppliers
Bortezomib
24 suppliers
Deferasirox
24 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo